#66 Seasoned Biotech Executive talks T-Cell Therapy and Running a Business in 2023!
Listen now
Description
On this episode of BioTech IQ, Ammon interviews Paul Lammers the CEO of Triumvira about developing autologus cell therapies using their T-Cell Antigen Coupler Platform (TAC). During this insightful discussion Paul talks about how he started in the industry, running a biotech company in today's environment, and what sets Triumvira's T-Cell therapy apart from the rest! Don't miss it!
Show support for show https://www.buymeacoffee.com/biotechiq
Check out the books recommended by Paul:
CEO Excellence - https://amzn.to/3OGjI3G
The Emperor of All Maladies - https://amzn.to/3IDyZ1l
Support the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/
More Episodes
Published 05/26/23
Bryan Kobel decided to pursue a career in biotech after seeing its massive opportunities to change the world. He sits down with Ammon Rivera to share how he translated his background as an investment banker into his role as the CEO of TC BioPharm, a company that develops cancer therapy. He opens...
Published 04/07/23
In this episode of BioTech IQ Ammon shares some real stats on the state of the hiring market in Biotech/pharma. We discuss what both job seekers and hiring managers can do to increase their success when searching/hiring. Bringing innovative treatments that make a difference in the life of people...
Published 03/17/23
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
